Diabetes mellitus type 2 secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The most important aspect of secondary prevention in diabetes mellitus type 2 is, to decrease the macrovascular mortality. Among the preventive measures, lipid control, [[smoking cessation]] and [[hypertension]] treatment are the most important ones. | |||
== Secondary Prevention == | == Secondary Prevention == | ||
Secondary prevention is focused to decrease the macrovascular complications. Application of effective strategies can result in up to 50% risk reduction in macrovascular complications.<ref name="pmid12556541">{{cite journal |vauthors=Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O |title=Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes |journal=N. Engl. J. Med. |volume=348 |issue=5 |pages=383–93 |year=2003 |pmid=12556541 |doi=10.1056/NEJMoa021778 |url=}}</ref> Effective measures in this case include:<ref name="pmid14734596">{{cite journal |vauthors=Saydah SH, Fradkin J, Cowie CC |title=Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes |journal=JAMA |volume=291 |issue=3 |pages=335–42 |year=2004 |pmid=14734596 |doi=10.1001/jama.291.3.335 |url=}}</ref> | Secondary prevention is focused to decrease the macrovascular complications. Application of effective strategies can result in up to 50% risk reduction in macrovascular complications.<ref name="pmid12556541">{{cite journal |vauthors=Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O |title=Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes |journal=N. Engl. J. Med. |volume=348 |issue=5 |pages=383–93 |year=2003 |pmid=12556541 |doi=10.1056/NEJMoa021778 |url=}}</ref> Effective measures in this case include:<ref name="pmid14734596">{{cite journal |vauthors=Saydah SH, Fradkin J, Cowie CC |title=Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes |journal=JAMA |volume=291 |issue=3 |pages=335–42 |year=2004 |pmid=14734596 |doi=10.1001/jama.291.3.335 |url=}}</ref> | ||
*Glycemic control | *[[Glycemic control]] | ||
*Treatment of lipid disorder | *Treatment of lipid disorder | ||
:Triglyceride level should be less than 150 mg/dL (1.7 mmol/L) and favorable HDL levels is >40 mg/dL (1.0 mmol/L) for men and >50 mg/dL (1.3 mmol/L) for women. | :[[Triglyceride]] level should be less than 150 mg/dL (1.7 mmol/L) and favorable [[HDL]] levels is >40 mg/dL (1.0 mmol/L) for men and >50 mg/dL (1.3 mmol/L) for women. | ||
:Statin treatment for preventive measures should be considered for all diabetic patients. The following table summarizes the statin therapy strategies: | :[[Statin]] treatment for preventive measures should be considered for all diabetic patients. The following table summarizes the statin therapy strategies: | ||
<span style="font-size:85%">'''Abbreviations:''' | <span style="font-size:85%">'''Abbreviations:''' | ||
'''CVD:''' Cardiovascular disease | '''CVD:''' Cardiovascular disease | ||
| Line 59: | Line 60: | ||
*Blood pressure control | *Blood pressure control | ||
:Blood pressure should be measured in every visits. Goal of blood pressure is less than 140/90 | :Blood pressure should be measured in every visits. Goal of blood pressure is less than 140/90 | ||
*Smoking cessation | *[[Smoking cessation]] | ||
*Using Aspirin | *Using [[Aspirin]] | ||
*Weight reduction | *Weight reduction | ||
*Vaccination including, annual influenza, pneumococcal vaccination and hepatitis B. | *Vaccination including, annual [[Influenza vaccine|influenza]], [[Pneumococcal vaccine|pneumococcal vaccination]] and [[Hepatitis B vaccine|hepatitis B]]. | ||
*Regular dental care | *Regular dental care | ||
*Regular foot care | *Regular foot care | ||
Revision as of 18:50, 17 March 2017
|
Diabetes mellitus type 2 Microchapters |
|
Differentiating Diabetes Mellitus Type 2 from other Diseases |
|
Diagnosis |
|
Treatment |
|
Medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
The most important aspect of secondary prevention in diabetes mellitus type 2 is, to decrease the macrovascular mortality. Among the preventive measures, lipid control, smoking cessation and hypertension treatment are the most important ones.
Secondary Prevention
Secondary prevention is focused to decrease the macrovascular complications. Application of effective strategies can result in up to 50% risk reduction in macrovascular complications.[1] Effective measures in this case include:[2]
- Glycemic control
- Treatment of lipid disorder
- Triglyceride level should be less than 150 mg/dL (1.7 mmol/L) and favorable HDL levels is >40 mg/dL (1.0 mmol/L) for men and >50 mg/dL (1.3 mmol/L) for women.
- Statin treatment for preventive measures should be considered for all diabetic patients. The following table summarizes the statin therapy strategies:
Abbreviations:
CVD: Cardiovascular disease
| Age | Risk factors | Recommended statin dose† |
|---|---|---|
| <40 years | None
CVD risk factor(s)¶ Overt CVDΔ |
None
Moderate or high High |
| 40 to 75 years | None
CVD risk factors Overt CVD |
Moderate
High High |
| >75 years | None
CVD risk factors Overt CVD |
Moderate
Moderate or high High |
† :In addition to lifestyle therapy.
¶ :CVD risk factors include LDL cholesterol ≥100 mg/dL (2.6 mmol/L), high blood pressure, smoking, and overweight and obesity.
Δ :Overt CVD includes those with previous cardiovascular events or acute coronary syndromes.
- Blood pressure control
- Blood pressure should be measured in every visits. Goal of blood pressure is less than 140/90
- Smoking cessation
- Using Aspirin
- Weight reduction
- Vaccination including, annual influenza, pneumococcal vaccination and hepatitis B.
- Regular dental care
- Regular foot care
References
- ↑ Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003). "Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes". N. Engl. J. Med. 348 (5): 383–93. doi:10.1056/NEJMoa021778. PMID 12556541.
- ↑ Saydah SH, Fradkin J, Cowie CC (2004). "Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes". JAMA. 291 (3): 335–42. doi:10.1001/jama.291.3.335. PMID 14734596.